MIGDAL HA’EMEQ, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the “Company”) today announced the pricing of a registered secondary public offering. The size of the offering has been increased to 4,698,857 ordinary shares at a price of $28.00 per share. The underwriters have a 30-day option to purchase up to an additional 704,828 ordinary shares at the public offering price. All of the shares are being sold by the Company’s shareholders. The Company will not receive any proceeds from the sale of these shares. The offering is expected to close on March 5, 2014, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
